Medicine
fromwww.mercurynews.com
3 weeks agoNew study shows promise for better TB treatments, California researchers say
CMX410 inhibits Pks13 in Mycobacterium tuberculosis, preventing cell wall synthesis and clearing drug-resistant infections in mice with no rat toxicity observed.